Catalytic mechanism of Phenylacetone monooxygenases for non-native linear substrates: implications on rational engineering of BVMOs to expand the substrate specificity by Carvalho, Alexandra T. P. et al.
Catalytic mechanism of Phenylacetone monooxygenases for non-
native linear substrates: implications on rational engineering of
BVMOs to expand the substrate specificity
Carvalho, A. T. P., Dourado, D. F. A. R., Skvortsov, T., de Abreu, M., Ferguson, L., Quinn, D. J., ... Huang, M.
(2017). Catalytic mechanism of Phenylacetone monooxygenases for non-native linear substrates: implications
on rational engineering of BVMOs to expand the substrate specificity. DOI: 10.1039/c7cp03640j
Published in:
Physical Chemistry Chemical Physics
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
Copyright 2017 Royal Society of Chemistry. This work is made available online in accordance with the publisher’s policies. Please refer to
any applicable terms of use of the publisher.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:09. Sep. 2018
 1
Catalytic mechanism of Phenylacetone 
monooxygenases for non-native linear substrates: 
implications on rational engineering of BVMOs 
to expand the substrate specificity 
Alexandra T.P. Carvalho, a,b, Daniel F.A.R. Dourado, a,b Timofey Skvortsov,b,c Miguel de Abreu,b 
Lyndsey J. Ferguson,b Derek J. Quinn, b Thomas S. Moody, b Meilan Huang a,*   
a. School of Chemistry and Chemical Engineering, Queen's University, David Keir Building, 
Stranmillis Road, Belfast BT9 5AG, Northern Ireland, UK 
b. Almac Sciences, Department of Biocatalysis and Isotope Chemistry, Almac House, 20 Seagoe 
Industrial Estate, Craigavon BT63 5QD, Northern Ireland, UK 
c. School of Biological Sciences, Queen’s University Belfast, Medical Biology Centre, 97 
Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK 
 
Corresponding Author 
E-mail: *m.huang@qub.ac.uk 
 
 
 
 
 2
ABSTRACT  
Phenylacetone monooxygenase (PAMO) is the most stable and thermo-tolerant member of the 
Baeyer-Villiger monooxygenases family, and therefore it is an ideal candidate for the synthesis 
of industrially relevant compounds. However, its limited substrate scope has largely limited its 
industrial applications. In the present work, we provide, for the first time, the catalytic 
mechanism of PAMO for the native substrate phenylacetone as well as for a linear non-native 
substrate 2-octanone, using molecular dynamics simulations, quantum mechanics and quantum 
mechanics/molecular mechanics calculations. We provide a theoretical basis for the preference 
of the enzyme for the native aromatic substrate over non-native linear substrates. Our study 
provides fundamental atomic-level insights that can be employed in the rational engineering of 
PAMO for wide applications in industrial biocatalysis, in particular, in the biotransformation of 
long-chain aliphatic oils into potential biodiesels.  
 
 1. Introduction  
The design of tailored enzymes for industrial synthetic applications is highly desirable as a cost-
effective and ecological friendly approach.1 Diverse enzymes can be obtained from directed 
evolution through random mutagenesis methods such as error-prone polymerase chain reaction 
(epPCR),2 DNA shuffling3 and saturation mutagenesis.4 Most of these methods do not require a 
previous knowledge of the protein structure and catalytic mechanism. However such approaches 
are time consuming, most mutations are neutral or even deleterious5-7 and the generated gene 
libraries (up to 1015 sequences) only represent a small fraction of the possible sequence space. 
Moreover, these methods usually require a large number of substitutions to achieve an enzyme 
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with the desired catalytic activity.8 This happens because in nature (and in random approaches) 
enzymes usually evolve through smooth weak trade-off routes where mutations accumulate 
keeping the robust native activity, while the promiscuous activities increase gradually.8 This type 
of route produces highly promiscuous generalist enzymes, which have low overall activities 
(including the main one) and hence require extensive modifications, in opposition to specialized 
enzymes that have higher catalytic proficiencies (defined as kcat/KM/kuncat). Rational mutagenesis 
guided by understanding of the substrates binding and catalytic mechanisms offers the possibility 
of overcoming these limitations by restraining the changes to a few amino acid positions with 
functional significance.9 
Baeyer-Villiger monooxygenases (BMVOs) are interesting targets for protein engineering. These 
enzymes are able to oxidize a variety of substrates such as cyclic or acyclic ketones into the 
corresponding lactones or esters.10-12 The catalytic cycles of BVMOs require nicotinamide-
adenine-dinucleotide phosphate 2'-monophosphoadenosine 5'-diphosphoribose (NADPH) and 
flavin-adenine dinucleotide (FAD) cofactors as well as molecular oxygen. Reduction of FAD by 
the NADPH cofactor and subsequent oxygenation leads to the formation of the highly reactive 
C4a-peroxyflavin intermediate (Fig. 1-Step A) that then attacks the carbonyl carbon of the 
substrate13 to yield a tetrahedral Criegee adduct (also called Criegee intermediate (Fig. 1-Step 
B))10, 14. In the next step this intermediate rearranges into the product (an ester or a lactone, 
depending on the initial substrate) and a C4a-hydroxyflavin intermediate (Fig. 1-Step C) that is 
then regenerated back to the flavin cofactor by dehydration.13 A QM/MM study on the catalytic 
mechanism of cyclohexanone monooxygenase (CHMO) indicates the reaction involves the 
formation of stable C4a-peroxyflavin and tetrahedral Criegee intermediates, which are stabilized 
by a catalytic arginine and NADP+ via strong hydrogen bonds.15 
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The prototype of the BVMO enzyme family is the Thermobifida fusca phenylacetone 
monooxygenase (PAMO).16 This enzyme is particularly thermo-stable, with an optimum 
temperature of 56 ° Celsius 17 and a tolerance for different solvents.16 However, it has a limited 
substrate scope. In opposition, other BVMOs, such as CHMO, catalyze a broader range of 
substrates,10, 13, 18 but are not as thermo-stable as PAMO, with an optimum temperature of around 
25-30 ° Celsius.19-22 Several studies attempted to introduce mutations on PAMO, aiming to 
increase the substrate scope by employing saturation mutagenesis approaches. Most of these 
studies were focused on the loop (residues 440-446) and remaining active site residues.23, 24 An 
exception was reported by Wu et al. who focused on distal residues.25 In the initial studies the 
mutations were shown to only affect the PAMO substrate specificity for the bulky substrate 2-
phenylcyclohexanone and its analogues. Deletion of S441 and A44223 or randomization of 
positions 441 to 444 increased its conversion, but with low enantioselectivity.26 Later, 
randomization of position 440 identified mutants with higher E-values for 2-
phenylcyclohexanone, that can also convert bulky substituted cyclohexanones.17 In addition, 
iterative saturation mutagenesis (ISM) of five active site residues identified mutants able to 
convert para-substituted cyclohexanone derivatives, although with lower conversion than the 
wild type (WT) CHMO.  More recently, starting from a triple mutant derived from combination 
of three previously identified mutations; F440P, Q93N and P94D,19, 23 mutants with higher 
cyclohexanone conversion and minimal trade-off in enzyme thermo-stability were generated by 
applying ISM. Additionally, in another study the M446G mutant was shown to increase the 
enantioselectivity for a range of ketone, amines and sulfides.27 Some of these mutations severely 
decreased the conversion of the native substrate.23 The aforementioned substrates are 
summarized in the supporting information (Fig. S1). Dudek et al. identified a PAMO mutant 
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with increased activity towards linear substrates by screening a random library composed of 
1,500 mutants.28 The best mutant, P253F/G254A/R258M/L443F, was shown to convert several 
substrates that could not be converted by the WT PAMO. The highest increase in activity was 
obtained for 2-octanone (19.2-fold increase in kcat/KM in relation to the WT enzyme).28 Recently, 
a large-scale biotransformation of ricinoleic acid into ester by engineered BVMO was reported, 
demonstrating the industrial application of BVMO-based whole-cell biocatalysis.29 Ricinoleic 
acid is the precursor of castor oil, a main resource in biodiesel production. Thus the potential 
application of engineered BVMO to catalyze unsaturated linear substrates in production of 
biofuels can be envisioned. 
In the present study we provide the rationale for PAMO’s discrimination between linear (2-
octanone) and aromatic (phenylacetone) substrates by performing molecular docking, classical 
molecular dynamics (MD) simulations, quantum mechanics (QM) calculations and quantum 
mechanics/molecular mechanics (QM/MM) simulations (Fig. S2).  This is the first atomic-level 
study to describe the complete PAMO catalytic pathway including binding of the two distinct 
substrates, formation of the corresponding Criegee intermediates and decay into the 
corresponding esters.  
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Fig. 1 Simplified catalytic mechanism of PAMO for the native substrate phenylacetone. The 
mechanism starts with reduction of the FAD by the cofactor NADPH. It is followed by reaction 
of the reduced FADH with molecular oxygen forming the C4a-peroxoflavin intermediate (Step 
A). In the presence of the substrate phenylacetone, the peroxyflavin oxygen attacks the substrate 
ketone forming a tetrahedral intermediate (the Criegee intermediate) (Step B), which is then 
resolved into C4a-hydroxyflavin and a product (ester or lactone) (Step C). Oxidized FAD is then 
regenerated by elimination of water and the NADP+ is released allowing for binding a new 
NADPH cofactor.  
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2. Experimental  
2.1 Computational methods  
2.1.1 Modelling  
The crystal structure of the flavin-peroxide intermediate of T. fusca PAMO  (pdb code: 2YLT) 
was used as the initial model system.30 This structure contains the FAD cofactor and the NADP+ 
cofactor (the 2-(n-morpholino)-ethanesulfonic acid inhibitor was removed). The crystal poses of 
the cofactors were kept. The peroxy form of FAD was generated with the peroxy group bound to 
the isoalloxazine ring of the FAD cofactor. The C4a-peroxyflavin was modeled in the anionic 
form due to stabilization by the surrounding catalytic residue Arg337 and anionic feature of the 
subsequently generated Criegee intermediate.  
The peroxy FAD, substrate, NADP+ and Criegee intermediates geometries were optimized using 
the Gaussian09 program31 with the B3LYP exchange-correlation functional32-34 and the 6-31G(d) 
basis set in the condensed phase. Point charges were calculated resorting to the RESP method35 
from HF/6-31G(d) single point energy calculations (Table S2, Table S3). Remaining parameters 
were obtained from the parm99SB36 and GAFF 37 force fields using the antechamber program in 
AMBER14. 38, 39 
 
2.1.2 Molecular Docking  
Molecular docking was performed using the AutoDock 4.2 suite of programs with the 
Lamarckian genetic algorithm (LGA).40 A grid box was centered on the oxygen of the peroxy 
group. R337 was set to be flexible. A total of 100 LGA runs were carried out for each 
ligand:protein complex. The population was 300, the maximum number of generations was 
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27,000 and the maximum number of energy evaluations was 2,500,000.  
 
2.1.3 Molecular dynamics 
MD simulations were performed using the Amber molecular dynamics program (AMBER14)38, 
39 with the parm99SB36 and GAFF37 force fields. The structures were placed within an octahedral 
box of TIP3P38 waters and counter ions were added to make the entire system neutral. The 
systems were subjected to two initial energy minimizations and to 500 ps of equilibration in a 
NVT ensemble using Langevin dynamics with small restraints on the protein (10 kcal/mol) to 
heat the system from 0K to 300 K. Production simulations were carried out at 300 K in the NPT 
ensemble using Langevin dynamics with a collision frequency of 1.0 ps–1. Constant pressure 
periodic boundary conditions were imposed with an average pressure of 1 atm. Isotropic position 
scaling was used to maintain pressure with a relaxation time of 2 ps. The time step was set to 2 
fs. SHAKE constraints were applied to all bonds involving hydrogen atoms.41 The particle mesh 
Ewald (PME) method42 was used to calculate electrostatic interactions with a cutoff distance of 
10 Å.  For each reactant complex three 20-ns simulations with random initial velocities were run, 
while for each Criegee intermediate a 10-ns simulation was run.  
 
2.1.4 QM cluster model calculations 
We built models of the active centre that include the isoalloxazine ring and two carbon atoms of 
the ribitol of the FAD cofactor, the substrate and the R337 side-chain (Fig. S2). 
The phenylacetone cluster model contains 73 atoms, while the 2-octanone model includes 78 
atoms. For both the phenylacetone and 2-octanone systems linear scans of the reaction steps B 
and C (Fig. 1) were performed. The reaction mechanism was studied at two different theoretical 
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levels: semi-empirical PM3 and dispersion corrected DFT. In the DFT study the exchange-
correlation functional B3LYP 32-34 along with the Grimme D3 dispersion correction43 was used 
with a 6-31G(d) basis set. The geometry optimizations were carried with the beta carbon (Cβ) of 
R337 and the C4a atom of the C4a-peroxyflavin kept fixed. In both cases, single point energies 
of the stationary states were recalculated with the conductor-like polarizable continuum model 
(CPCM) 44 45 with a dielectric constant of 4. In the DFT study the basis set was increased to 
B3LYP/6-311++G(d), following a similar protocol applied in previous literature.46 Frequency 
calculations were performed to confirm the nature of the transition state structures and 
intermediates as well as introduce zero-point and thermal corrections to the final energies. All 
QM calculations were performed using Gaussian09 program31. 
 
2.1.5 QM/MM calculations  
The QM/MM calculations were performed using the internal semi-empirical hybrid QM/MM 
functionality implemented in AMBER1447 with periodic boundary conditions. The PM3 semi-
empirical method was employed for the high level layer and the MM region was described by the 
Amber parm99SB force field. The high level layer includes the substrate, the side chain atoms of 
R337, the isoalloxazine ring of the peroxyflavin cofactor and the nicotinamide and ribose rings 
of the NADP+ cofactor (Fig. S2). The QM layer of the enzyme-phenylacetone complex contains 
a total of 123 atoms while that of the enzyme-2-octanone complex contains 128 atoms.  
The boundary was treated via the link atom approach and long-range electrostatic interactions 
were described with an adapted implementation of the PME method for QM/MM.47  Electrostatic 
embedding was employed.48 
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The reaction coordinate for the formation of the Criegee intermediate (Fig. 1 - Step B) was 
defined as the distance between the peroxy oxygen of the peroxyflavin cofactor and the carbonyl 
carbon (C2) of the substrate (dOX-C2). The reaction coordinate for the decay of the Criegee 
intermediate into benzyl acetate (Fig. 1 - Step C) was defined as the distance between the same 
oxygen and the C3 carbon (dOX-C3). The distances were restrained to decrements of 0.1 Å using 
the umbrella sampling method, except that decrements of 0.02 Å were employed near the 
transition states for step B. Each sampling window was run for 200 ps. The potential of mean 
force (PMF) was calculated resorting to the WHAM method.49  
The main limitation of the PM3 Hamiltonian is the fact that it was parameterized to reproduce 
gas phase geometries and heats of formation for molecules in their ground states while the 
transition states were left out from the training set. However, the QM/MM with the QM region 
treated with PM3 has been shown to provide reasonable geometries in numerous enzyme studies. 
50-52 Moreover, it is worth noting that the non-enzymatically catalyzed Baeyer-Villiger reaction 
was previously studied using PM3 and returned results in agreement with experimental data.53, 54 
For each substrate studied we calculated the PMF with PM3 and then applied high level 
corrections to these energies, following the protocol reported in previous literature.55 Provided 
that the interaction energy of the QM/MM does not change significantly at both levels of theory, 
the corrected free energy of the PMFs can be described by equation (1). 
∆ܩ௉ெி,௖௢௥௥ሺ݌ݎ݋ݐ݁݅݊ሻ ൌ ∆ܩ௉ெி,௉ெଷሺ݌ݎ݋ݐ݁݅݊ሻ ൅ ሾ∆ܩ஽ி்ሺ݉݋݈݀݁ሻ െ ∆ܩ௉ெଷሺ݉݋݈݀݁ሻሿ  (1) 
∆ܩ஽ி்ሺ݉݋݈݀݁ሻ - ∆ܩ௉ெଷሺ݉݋݈݀݁ሻ, is the difference in the free energies for the QM layer model 
calculated by PM3 and B3LYP/6-31G(d), respectively.  
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Assuming that the thermal and zero point energy corrections are small and thus negligible, the 
corrected free energy of the PMF can also be described by equation (2). 
∆ܩ௉ெி,௖௢௥௥ሺ݌ݎ݋ݐ݁݅݊ሻ ൌ ∆ܩ௉ெி,௉ெଷሺ݌ݎ݋ݐ݁݅݊ሻ ൅ ሾܧ஽ி்ሺ݉݋݈݀݁ሻ െ ܧ௉ெଷሺ݉݋݈݀݁ሻሿ     (2) 
ܧ஽ி்ሺ݉݋݈݀݁ሻ - ܧ௉ெଷሺ݉݋݈݀݁ሻ corresponds to the difference in the energies of the stationary 
points that were optimized using PM3 and DFT (B3LYP using a 6-31G(d) basis set and B3LYP 
along with the Grimme D3 dispersion correction43 using a TZVP basis set methods) . The 
correction was first performed for the reagents and products. For the rest of the potential energy 
surface, the correction was interpolated by incrementally adding to each point a correction factor, 
which is defined as the energy difference between the two stationary points divided by the 
number of points along the reaction coordinates. 
 
2.2 Experimental Methods 
 
2.2.1 Chemicals, Strain and Plasmid 
Chemicals were purchased from Sigma Aldrich UK. The PAMO sequence of 1,638 bp 
(accession code: Q47PU3) was cloned into the pET-28a(+) plasmid utilising the NdeI and XhoI 
restriction sites. 
 
2.2.2 Protein expression and purification 
E.coli cultures were incubated overnight in 5mL LB media supplemented with kanamycin (50 
mg/mL) in a shaking incubator at 37°C. Cultures were added to 1 L LB media supplemented 
with kanamycin and incubated at 37°C to OD600 = 0.5. Cultures were induced by the addition of 
IPTG (1 mM final concentration) to the culture media and incubated at 25°C for 16h. After 
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incubation, the cell pellets were collected by centrifugation (5000 rpm at 4°C) and resuspended 
in 100mM Tris buffer pH 7.4. Cells were lysed by sonication on ice 10 x 10 s separated by a 1 
min interval. Cell debris was removed by centrifugation (30 min at 5000rpm) at 4°C. The protein 
was purified using the HisPurTM Cobalt Resin protocol (Thermo ScientificTM). Protein 
concentration was determined using Bradford protocol described by Sigma-Aldrich. Protein 
purification was conducted under mild conditions to prevent the loss of the flavin cofactor. The 
recombinant proteins displayed brightly yellow colour in the solution, indicating the presence of 
FAD prosthetic group. The concentration of FAD-bound PAMO was determined by measuring 
the absorbance of the protein at 441 nm.  The extinction coefficient for FAD-bound PAMO (ε441 
= 12.4 mM−1 cm−1) was previously obtained by Fraaije et al.16 The protein concentration of the 
Bradford assay and the concentration of the FAD-bound PAMO were compared and a molar 
ratio of 1:1 was obtained for the wild-type enzyme.   
 
2.2.3 Characterization of enzymes 
The kinetic parameters of the wild-type PAMO were determined using 96-well plate assay. The 
conditions used for kinetic analysis assays were as follows: 50 mM Tris·Cl (pH 7.4), 100 µM 
NADPH, 5% 1,4-dioxane (v/v), 200 µl final volume. All reactions were set up in triplicates and 
conducted at 25°C. The reactions were initiated by adding NADPH and monitored by 
continuously measuring the absorbance of the reaction plate samples at 340 nm (ε340 = 6.22 
mM−1 cm−1) using Epoch Microplate Spectrophotometer (BioTek, USA). The substrate was in 
the range of 10 – 5000 µM, while the final concentration of enzymes present in the reaction was 
in the range 0.1–1.0 μM. The GraphPad Software v6 (GraphPad Software, USA) was used to fit 
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the data and to obtain the kinetic parameters (Fig. S6, Table 1). The program is based on the 
following formula: 56 
V=Vmax*[S]/(KM + [S]*(1+[S]/Ki)),  
where: 
Vmax is the maximum enzyme velocity, 
[S] is the substrate concentration, 
V is the velocity, 
KM is the Michaelis-Menten constant, 
Ki is the dissociation constant for the inhibitory ESS ternary complex. 
 
3. Results and Discussion  
3.1 Catalytic mechanism of WT PAMO towards phenylacetone and 2-octanone  
3.1.1 Substrate binding  
MD simulations of the complex enzyme:NADP+:FADOO- with the native substrate 
phenylacetone shows that the substrate establishes few interactions with the enzyme and 
cofactors. The strongest interaction is a cation-π interaction between the phenyl group of 
substrate and the conserved R337 residue. R337 is in close proximity with the FAD cofactor as 
disclosed in the first crystal structure,57 indicating that R337 might have an important role in 
PAMO’s catalytic mechanism. Mutations of this residue (R337A and R337K) demonstrated loss 
of activity towards phenylacetone, which further proved the catalytic importance of this 
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residue.13 In the simulations the average distance between the centers of mass of the phenyl ring 
in the substrate and the side chain of R337 is 4.21±0.42 Å. The carbonyl group in the ketone 
moiety is in close proximity of the isoalloxazine ring of the C4a-peroxyflavin cofactor, while the 
methyl group interacts via London dispersion forces with A442, M446, which are located on an 
active site loop (residues 440-446) previously shown to alter the conversion and 
enantioselectivity of either bulky cyclohexanone substituents or sulfides.23, 58 Throughout the 
simulations the distance between the attacking oxygen atom of the C4a-peroxyflavin and the 
substrate carbonyl carbon atom (dOX1_C2) was retained around 3 Å, a favorable distance for the 
reaction to occur (Fig. 2, S4).  
MD simulations were also conducted for the linear non-native substrate 2-octanone. The long 
aliphatic tail of 2-octanone interacts with the aliphatic part of the R337 side chain.  In addition, it 
also interacts with P286, L338 and L340 via weak London dispersion forces. This represents a 
catalytically relevant pose where the peroxy-FAD oxygen is close to the carbonyl carbon of the 
substrate (replica 1& 3, Fig. 3A). It is worth mentioning that the hydrophobic interactions 
formed with P286, L338 and L340 do not necessarily always prompt the substrate to adopt a 
catalytically relevant pose. In one of the replicas (replica 2), the carbonyl moiety moves away 
from the C4a-peroxyflavin cofactor to establish an ion-dipole interaction with a second arginine 
R258 that is nested at the entrance of the active site pocket (Fig. 3B, S4).  
Thus, it appears that the ability of PAMO to bind aromatic substrates in a catalytically relevant 
pose is attributed to the cation-π interaction with the conserved R337 in the relatively large 
substrate pocket. While this interaction is absent in the case of the linear substrate 2-octanone, it 
is compensated by the weak interactions formed with P286, L338 and L340. To further validate 
this hypothesis and to ascertain any other factors that contribute for the discrimination of 
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aromatic and linear substrates, we examined the chemical reaction path concerning the formation 
and decay of the Criegee intermediate using QM and QM/MM methods, respectively (Tables 2 
and 3, Fig. 4 and 5).                          
 
Fig. 2 A) Crystal structure of the WT PAMO (pdb code: 2YLT) in complex with the modelled 
C4a-peroxyflavin intermediate and the native substrate phenylacetone docked into the active site; 
B) MD reference structure of the same complex. The MD reference structure corresponds to the 
lowest RMSD structure in relation to the average structure of the simulation. No significant 
changes were observed in the MD replicas. Relevant distances are shown (Å). 
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Fig. 3 A) Crystal structure of the WT PAMO (pdb code: 2YLT) in complex with the modeled 
C4a-peroxyflavin intermediate and the non-native substrate 2-octanone docked into the active 
site; B) MD reference structure of the replica 1 (replica 3 is similar to replica 1). C) MD 
reference structure of replica 2. The MD reference structure corresponds to the lowest RMSD 
structure in relation to the average structure of the simulation. Relevant distances are shown (Å). 
 
3.1.2 Formation of the Criegee intermediate and decay into the ester product 
The kinetic parameters associated with PAMO catalysis of phenylacetone were previously 
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measured.13 The kcat is 1.9 s-1 at 25°C, which corresponds to a free energy barrier of 17.1 
kcal/mol, and the KM is 0.059 mM.16 The kinetic parameters for 2-octanone were not accurately 
determined due to substrate solubility issues in the previous assays,28 where an approximate kcat 
of  > 1 s-1  at 37°C (corresponding to an free energy barrier of < 18.2 kcal/mol) and a KM of >2 
mM were reported. In order to compare the PAMO–catalyzed conversion of the two substrates,  
we determined the steady-state kinetic parameters associated with the conversion of 2-octanone, 
and obtained a kcat value of 0.22 s-1 at 25°C (corresponding to a free energy barrier of 18.4 
kcal/mol) and a KM of 3.2 mM (Table 1).   
Table 1 Steady-state kinetic parameters of PAMO WT for the conversion of 2-octanone. The 
values obtained are averaged results of three measurements. Kinetic parameters were determined 
with GraphPad Prism 6; the kinetic curves were fitted using Michaelis-Menten equation for 
substrate inhibition (Fig. S6).  
 WT PAMO 
KM [mM] 3.2 
kcat [s-1] 0.22 
kcat/KM [M-1 s-1] 66 
 
In the reaction catalyzed by CHMO, a covalent adduct between the substrate and the cofactor, 
the so-called Criegee intermediate, is obtained by nucleophilic attack of the substrate 
cyclohexanone by the C4a-peroxyflavin, which subsequently undergoes fragmentation to form 
the lactone product.15 The reaction mechanism for PAMO-catalyzed oxidation of phenylacetone 
may also occur via the formation of a Criegee intermediate that then decays into benzyl acetate 
(Fig. 1). To elucidate the catalytic mechanism of PAMO for native substrate phenylacetone and 
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non-native substrate 2-octanone, we conducted QM cluster calculations and QM/MM MD 
simulations to explore the respective reaction pathways for the two substrates. 
3.1.2.1 QM Cluster Models 
We built cluster models of the active centers for both the phenylacetone and 2-octanone 
substrates and calculated their respective reaction paths with DFT (B3LYP-D) method (Table 2 
and S1). The optimized structures of the transition states are shown in Fig. 4.   
For phenylacetone, the formation of the Criegee intermediate (Fig. 1 - Step B) is associated with 
an activation free energy (∆G‡TS1) of 5.2 kcal/mol, while the reaction free energy (∆Gr) is 6.4 
kcal/mol (Fig. 5A, Table 2). The subsequent step, which corresponds to the decay into the ester 
(Fig. 1 - Step C), has a free energy barrier (∆G‡TS2) of 10.3 kcal/mol and a ∆Gr of -68.9 kcal/mol 
(Fig. 5A, Table 2).  
                      
Fig. 4 QM cluster model calculations. DFT (B3LYP-D/6-31G(d)) optimized geometries of: (A) 
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and (B) TS1 and TS2 of phenylacetone complex; (C) and (D) TS1 and TS2 of 2-octanone 
complex. Relevant distances are reported in Table S1.  
The overall energy barrier (∆G‡‡), which corresponds to the energy difference between the initial 
reactant complex (denoted as RC hereafter) and TS2, is 16.7 kcal/mol (Table 2). So our 
calculated ∆G‡‡ is well in line with the experimentally determined kinetic constant which 
corresponds to an energy barrier of 17.1 kcal/mol at 25°C. 16  
For 2-octanone, step B has a ∆G‡TS1 of 7.0 kcal/mol and a ∆Gr of 5.5 kcal/mol, while Step C has 
a ∆G‡TS2 of 13.2 kcal/mol and a ∆Gr of -71.6 kcal/mol (Fig. 5B, Table 2). The overall energy 
barrier ∆G‡‡ is 18.7 kcal/mol, which is line with the experimentally measured energy barrier of 
18.4 kcal/mol.  Thus, our in silico calculations and kinetic results for the two substrates showed 
similar reaction profiles, indicating that 2-octanone follows a similar reaction mechanism to the 
native substrate phenylacetone.  
The predicted ∆G‡‡ for the linear substrate 2-octanone is only 2.0 kcal/mol higher than that of the 
phenylacetone. This is not surprising since the experimental data indicates a difference of 1.6 
kcal/mol and the catalytic reaction coordinates of TS2 derived from the Criegee intermediate for 
2-octanone are similar to those of the corresponding transition state derived from the Criegee 
intermediate for phenylacetone. 
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Fig. 5 Gibbs free energies (in kcal/mol) of the optimized stationary points along the reaction path 
at 298.15 K for: A) phenylactone; B) 2-octanone. Optimized geometries were taken from both 
the PM3 and DFT (B3LYP-D/6-31G(d)) potential energy surfaces and frequencies calculated at 
the respective theory levels. The energies of the stationary points were further corrected using a 
larger basis set 6-311++G(d) in the DFT based reaction profiles. Energies of the stationary points 
were obtained in the condensed phase (PM3 (blue), B3LYP/6-311++G(d) (black)) with the self-
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consistent reaction field CPCM and with a dielectric constant of 4. Zero point energy and 
thermal corrections were also added. INT stands for Criegee intermediate. 
Table 2 Gibbs free energies (in kcal/mol) of the optimized stationary points along the reaction 
path , based on the cluster model calculations using the semi-empirical PM3 and DFT-D with a 
continuum description. Full geometry optimization were conducted with B3LYP-D/6-31G(d) 
followed by single point energy calculations using B3LYP-D/6-311++G(d), in the DFT-D 
calculations. The protein environment was considered by using the self-consistent reaction field 
CPCM with a dielectric constant of 4.  All the energies reported are in relation to the initial 
reactant complex.  
 phenylacetone 2-octanone 
 ΔGPM3 ΔGDFT-D ΔGPM3 ΔGDFT-D 
RC 0 0 0 0 
TS1 12.9 5.2 16.1 7.0 
INT 6.5 6.4 8.9 5.5 
TS2 16.3 16.7 17.6 18.7 
PC -68.2 -62.5 -62.9 -66.1 
 
We also conducted the same calculations using the PM3 semi-empirical to test its accuracy for 
these model systems. . For both substrates the predicted ∆G‡‡ barriers calculated using PM3 are 
similar to the ones obtained with DFT (Fig. 5, Table 2). For phenylacetone the difference 
calculated using the two methods is only 0.4 kcal/mol, while for 2-octanone it is 1.1 kcal/mol. 
 22
However, when analyzing the energy barriers of the individual reaction steps, we find that the 
energy barriers of Step B calculated using PM3 are substantially higher than the ones calculated 
with the DFT method (Fig. 5A, Table 2). The energy difference in ∆G‡TS1 estimated using the 
two methods is 7.7 kcal/mol for phenylacetone and 9.1 kcal/mol for 2-octanone, respectively 
(Table 2). For Step C of phenylacetone, the energy difference in ∆G‡TS2 calculated by the two 
methods is insignificant (0.5 kcal/mol), since the differences in energies of both TS2 and the 
Criegee intermediate are negligible. However, a notable energy difference of 4.5 kcal/mol is 
observed for 2-octanone due to the distinct energies of the Criegee intermediates obtained with 
PM3 and DFT (Fig. 5B, Table 2). Therefore, in the subsequent QM/MM simulations we applied 
high-level quantum chemical (DFT) corrections to the PMF-based free energy profile for each 
reaction step to account for any possible energy differences between the methods.   
 
3.1.2.2 QM/MM model 
Although the cluster model calculations provided important insights into the reaction mechanism 
and the obtained energy barriers are in line with the experimental data, only a limited number of 
residues of the protein were taken in account. In order to identify other residues that might also 
be involved in the reaction mechanism so as to guide in the rational engineering of the enzyme, 
we employed a hybrid QM/MM method to sample the energy profiles of the entire protein 
complexes. The QM layer was calculated with the PM3 Hamiltonian (Fig. S2). In addition, DFT 
corrections were applied to the energy profiles as described in previous literature. 55 
For phenylacetone, the Step B that corresponds to the formation of the Criegee intermediate has 
a ∆G‡TS1 of 16.2 kcal/mol (Fig. 6A), while ∆Gr is 6.0 kcal/mol. Step C, which corresponds to the 
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decay into the ester, has a ∆G‡ TS2 of 7.9 kcal/mol and a ∆Gr of -34.3 kcal/mol. The overall ∆G‡‡ 
is 13.9 kcal/mol. With DFT (B3LYP/TZVP) corrections applied to the QM layer, the ∆G‡ TS1 of 
step B becomes 15.7 kcal/mol and ∆Gr is 5.4 kcal/mol, while the ∆G‡ TS2 is 9.9 kcal/mol (Table 
3). The corrected ∆G‡‡ becomes 15.3 kcal/mol, which is close to the experimental measured 
barrier (17.1 kcal/mol).16 The energy difference is within the error of the computational method. 
Correction at the B3LYP/6-31G(d) level was also applied to the QM layer (Table 3). It is worth 
noting that the corrected ∆G‡‡ is close to ∆G‡ TS1 with either B3LYP/TZVP (15.3 versus 15.7 
kcal/mol) or B3LYP/6-31G(d) corrections (15.5 versus 15.4 kcal/mol) (Table 3).  
Fig. 6 QM/MM Gibbs free energies profile for the WT PAMO catalyzed reaction to convert (A) 
phenylactone and (B) 2-octanone. Dashed line denotes the energies calculated using 
PM3/Amber_parm99SB and solid line denotes the corrected energies using B3LYP/TZVP. Step 
B: addition of the substrate to the C4a-peroxyflavin (RC). Step C: decay of the Criegee 
intermediates (INT) to the corresponding esters (PC).  
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Table 3 Gibbs free energies (kcal/mol) from QM/MM models. The energies were corrected by 
full geometry optimizations using B3LYP/6-31G(d) and B3LYP/TZVP with empirical 
dispersion. 
B3LYP/6-31G(d) 
 Step B Step C ΔG‡‡  Exp. Error 
∆G‡TS1 ΔGr ∆G‡TS2 ΔGr 
phenylacetone 15.4 4.7 10.8 -25.4 15.5 17.1 -1.3 
2-octanone 16.4 10.0 10.1 -27.4 20.1 18.4 1.7 
B3LYP/TZVP 
 Step B Step C ΔG‡‡ Exp. Error 
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 ∆G‡TS1 ΔGr ∆G‡TS2 ΔGr 
phenylacetone 15.7 5.4 9.9 -27.9 15.3 17.1 -1.8 
2-octanone 14.5 7.4 9.8 -28.5 17.2 18.4 -1.2 
 
The conversion of the linear substrate 2-octanone follows a similar catalytic mechanism, which 
is accordance to what was found in the QM cluster model study that indicates the formation of a 
Criegee intermediate. For step B we obtained a ∆G‡TS1 of 14.9 kcal/mol and a ∆Gr of 8.0 
kcal/mol (Fig. 6B). For step C ∆G‡TS2 is 7.1 kcal/mol and ∆Gr is -39.7 kcal/mol. This 
corresponds to an overall ∆G‡‡ of 15.1 kcal/mol. With corrections applied to the QM layer 
(B3LYP/TZVP), the ∆G‡ TS1 of step B becomes 14.5 kcal/mol and ∆Gr is 7.4, while the ∆G‡ TS2 is 
9.8 kcal/mol (Table 3). The overall ∆G‡‡ becomes 17.2 kcal/mol, which is, as expected, higher 
than the predicted energy barrier for phenylacetone and also in good agreement with 
experimental kinetic data that corresponds to an overall energy barrier of 18.4 kcal/mol. We also 
introduced corrections for the QM layer using the 6-31G(d) basis set. The results show that 
B3LYP/6-31G(d) correction gives reasonable ∆G‡‡ energy barriers in relation to the 
experimental data (Table 3).   
Based on the above QM cluster calculations and QM/MM simulations, it is evident that in the 
reaction catalyzed by PAMO, both the native substrate phenylacetone and the non-native 
aliphatic substrate 2-octanone are subjected to nucleophilic attack by the deprotonated C4a-
peroxyflavin to form a Criegee intermediate, which then decays into their respective ester 
products. Taking together the mechanism of CHMO proposed by Polyak et al.,15 we demonstrate 
that the Criegee intermediates in PAMO needs to undergo similar fragmentation to yield the 
product. 
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3.1.3 Alkyl migration in decay of the Criegee intermediate of 2-octanone  
Decay of the Criegee intermediate of 2-octanone via the aforementioned n-hexyl migration gives 
the normal product, whereas an abnormal product may also be yielded with the migration of the 
methyl group. It would be interesting to decide the migratory preference of the n-hexyl group in 
relation to the methyl group. To present a whole mechanistic picture, we also calculated the 
potential energy surface corresponding to the methyl migration using QM/MM 
(PM3/Amber_parm99SB) simulations, plotting the free energy of the enzyme system as a 
function of the distance between the distal oxygen atom of the C4a-peroxoflavin peroxy group 
and the carbon atom of the methyl group in 2-octanone (Fig. S5). We found that the methyl 
migration is associated with a much higher free energy barrier than the n-hexyl migration (27.4 
kcal/mol versus 15.1 kcal/mol). The large difference in the energy barriers indicates the decay of 
the Criegee intermediate of 2-octanone preferably undergoes the n-hexyl migration, and 
therefore produces the normal product rather than the abnormal product.  
2.1.4 MD simulations of the Criegee intermediates  
We also performed MD simulations for the Criegee intermediates of phenylacetone and 2-
octanone (Fig. 7). Similar to the substrate binding, the Criegee intermediate of the native 
substrate establishes a cation-π interaction with R337 (Fig. 7A), whereas for the intermediate of 
2-octanone only weak London dispersion interactions are observed between its aliphatic tail and 
residues L289, L338 and L340 (Fig. 7B).  
Thus the difference in catalytic proficiencies of the WT PAMO towards the two distinct 
substrates is attributed to the different binding modes of the substrates as well as the 
corresponding Criegee intermediates.  
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Fig. 7  MD reference structure of the Criegee intermediates for the WT PAMO that forms a 
tetrahedral covalent adduct with: A) phenylacetone; B) 2-octanone. The structures correspond to 
the ones with lowest RMSD compared to the respective average MD structures. No significant 
changes were observed in the MD replicas. The aliphatic tail of the 2-octanone adduct 
establishes interactions with L289, L338 and L340.  
 
 
4. Conclusions  
The high stability and thermo-tolerance of the flavoprotein PAMO makes it an ideal biocatalyst 
for the oxidation of ketones. However, its limited substrate scope precludes its broader 
application in industry. The catalytic mechanisms of PAMO calculated by DFT cluster models 
and QM/MM simulations demonstrate the effective energy barriers are in good accordance with 
 28
experimental data. This research provides atomic level insight on the catalytic mechanism for 
phenylacetone, and provides, for the first time, a description of the mechanism for a linear 
substrate 2-octanone.  
The native substrate phenylacetone makes a cation-π interaction with the conserved R337, which 
in turn interacts with the peroxy moiety of the C4a-peroxyflavin cofactor. It is this mutual 
interaction that keeps the substrate in place in the wide active site pocket of the enzyme to 
facilitate the formation of the Criegee intermediate. In contrast, the missing cation-π interaction 
for linear substrates such as 2-octanone is compensated by the weak interactions formed between 
the aliphatic tail of the substrate and a hydrophobic region constituted by P286, L338 and L340. 
The weak interactions enable the carbonyl end of the substrate to move more freely in the 
binding pocket, as a consequence, it may move towards R258 to form an ion-dipole interaction.  
We observed that in the enzyme catalyzed reactions both substrates have similar free energy 
barriers in TS1, which corresponds to the formation of the Criegee intermediate. The overall 
barrier ∆G‡‡ is higher for 2-octanone than the native substrate phenolacetone, as a result of 
energy differences in the Criegee intermediates and TS2s.  
Our study has shown that additional design efforts should be made in improving the binding of 
the linear substrates as well as of the corresponding Criegee intermediates. The calculations 
showed that it is possible to reshape the relatively large active site pocket of PAMO by 
introducing mutations that would result in preferential interactions with the aliphatic part of this 
substrate, while the substrate remains close to the C4a-peroxyflavin. These hydrophobic 
interactions would improve the binding of 2-octanone as well as allow the corresponding Criegee 
intermediate to be properly stabilized.  
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In summary we find the spatial requirement essential for improvement in the binding and 
conversion of long aliphatic substrates by BVMOs, which may provide significant insight in 
rationally engineering the enzymes for industrial production of biofuels such as castor oils. 
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